Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 9/20 | 0.59 |
| ▸ | MAOB | P27338 | 9/20 | 0.59 |
| ▸ | PRKCI | P41743 | 1/20 | 0.56 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.50 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.49 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | GRM5 | P41594 | 1/20 | 0.47 |
| ▸ | SRD5A1 | P18405 | 2/20 | 0.46 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.46 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
| ▸ | CASP7 | P55210 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL315877 | 0.96 | MAOA (0.61) | MAOAMAOBPRKCIHSD17B1MAPK14 | |
| SCHEMBL29726050 | 0.88 | CASP1 (0.59) | MAOAMAOBPRKCIHSD17B1GRM5 | |
| SCHEMBL192610 | 0.88 | CASP1 (0.59) | MAOAMAOBPRKCIHSD17B1GRM5 | |
| SCHEMBL4017169 | 0.84 | PARP1 (0.53) | MAOAMAOBPRKCIHSD17B1MAPK14 | |
| SCHEMBL7506302 | 0.82 | HSD17B1 (0.71) | MAOAMAOBPRKCIHSD17B1MAPK14 | |
| SCHEMBL7507475 | 0.81 | HSD17B1 (0.56) | MAOAMAOBPRKCIHSD17B1CYP2A6 | |
| SCHEMBL769238 | 0.80 | MAOA (0.53) | MAOAMAOBPRKCIHSD17B1CYP2A6 | |
| SCHEMBL29446042 | 0.80 | MAOA (0.53) | MAOAMAOBPRKCIHSD17B1CYP2A6 | |
| Hydrochloric Acid SCHEMBL9827967 | 0.79 | MAOA (0.48) | MAOAMAOBPRKCIHSD17B1MAPK14 | |
| SCHEMBL4428197 | 0.78 | PARP10 (0.61) | MAOAMAOBPRKCIHSD17B1MAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3746064-B1 | COMPOUNDS FOR USE IN THE TREATMENT OF ACUTE BRAIN INJURY | UNIV COPENHAGEN (DK) | 2025-04-16 | — | — | EP | disclosed |
| US-20240391865-A1 | COMPOUNDS FOR THE TREATMENT OF ACUTE BRAIN INJURY | OTAGO INNOVATION LIMITED (NZ) | 2024-11-28 | — | — | US | disclosed |
| US-12077495-B2 | Compounds for the treatment of acute brain injury | Københavns Universitet (DK) | 2024-09-03 | — | — | US | disclosed |
| US-20210122700-A1 | COMPOUNDS FOR THE TREATMENT OF ACUTE BRAIN INJURY | UNIVERSITY OF OTAGO (NZ) | 2021-04-29 | — | — | US | disclosed |
| US-9520574-B2 | Electroluminescent devices based on phosphorescent iridium and related group VIII metal multicyclic compounds | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2016-12-13 | — | — | US | disclosed |
| US-20130082248-A1 | ELECTROLUMINESCENT DEVICES BASED ON PHOSPHORESCENT IRIDIUM AND RELATED GROUP VIII METAL MULTICYCLIC COMPOUNDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2013-04-04 | — | — | US | disclosed |
| EP-2564446-A1 | ELECTROLUMINESCENT DEVICES BASED ON PHOSPHORESCENT IRIDIUM AND RELATED GROUP VIII METAL MULTICYCLIC COMPOUNDS | Commonwealth Scientific and Industrial Research Organisation (AU) | 2013-03-06 | — | — | EP | disclosed |
| WO-2011134013-A1 | ELECTROLUMINESCENT DEVICES BASED ON PHOSPHORESCENT IRIDIUM AND RELATED GROUP VIII METAL MULTICYCLIC COMPOUNDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2011-11-03 | — | — | WO | disclosed |
| EP-1741693-B1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE ALCOHOLS | NAGOYA IND SCIENCE RES INST (JP) | 2011-08-03 | — | — | EP | disclosed |
| US-20070225528-A1 | Process for Producing Optically Active Alcohol | NAGOYA INDUSTRIAL SCIENCE RESEARCH CENTER (JP) | 2007-09-27 | — | — | US | disclosed |
| EP-1741693-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE ALCOHOLS | Nagoya Industrial Science Research Institute (JP) | 2007-01-10 | — | — | EP | disclosed |
| US-6316437-B1 | ADRENERGIC RECEPTOR ANTAGONISTS | MERCK & CO., INC. | 2001-11-13 | — | — | US | disclosed |
| US-4977152-A | For alzheimer*s disease | SOCIETE ANONYME: SANOFI (FR) | 1990-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070225528-A1 | Process for Producing Optically Active Alcohol | ADH1C, ADH1A, ADH5 | MAOA 2342/4885MAOB 1866/4885PRKCI 1124/4885 |
| US-12077495-B2 | Compounds for the treatment of acute brain injury | F2R, F2RL3, ARG2 | MAOA 925/4885MAOB 620/4885PRKCI 3411/4885 |
| US-20210122700-A1 | COMPOUNDS FOR THE TREATMENT OF ACUTE BRAIN INJURY | F2R, F2RL3, ARG2 | MAOA 922/4885MAOB 654/4885PRKCI 3384/4885 |
| US-20240391865-A1 | COMPOUNDS FOR THE TREATMENT OF ACUTE BRAIN INJURY | F2R, F2RL3, ARG2 | MAOA 922/4885MAOB 654/4885PRKCI 3384/4885 |
| US-20130082248-A1 | ELECTROLUMINESCENT DEVICES BASED ON PHOSPHORESCENT IRIDIUM AND RELATED GROUP VIII METAL MULTICYCLIC COMPOUNDS | ICOSLG, ETV6, ROS1 | MAOA 2542/4885MAOB 2970/4885PRKCI 1700/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.